TheEdgeResearch
Home / Stocks / BBNX

Beta Bionics, Inc. (BBNX)

NASDAQ Healthcare Medical - Equipment & Services
$11.96 ▼ -1.36%
Market Cap
$532.7M
Sector
Healthcare
Industry
Medical - Equipment & Services
Beta
3.39
52-Wk Range
8.8-32.71
CEO
Sean T. Saint
Country
US
Currency
USD

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon;…

Open full interactive analysis & DCF →